Featured

JAX Tech Talk # 51: Let’s Talk Accelerating Research with JAX’s GvHD Platform (1 Mar 2022)



Published
March 1, 2022 - In addition to providing researchers with genetically stable, high health status NSG™ mice and study-ready hu-PBMC mice, The Jackson Laboratory also helps design and execute studies to evaluate the efficacy of drugs to treat GvHD. In this episode, the JAX Tech Talk Team welcomes Prabir Banerjee to discuss the JAX GvHD platform and its value in accelerating  your preclinical research studies. Join us to learn about the unique benefits of JAX’s GvHD platform and have your questions answered LIVE by our experts.

Helpful Resources:

Graft versus Host Disease (GvHD) Efficacy Studies
https://bit.ly/3gLpf75

GvHD Efficacy Study Fact Sheet
https://bit.ly/3GIyVK8

Blog Post: Investigating Immunomodulation: Examining GvHD Using Humanized NSG™ from JAX Mice
https://bit.ly/3HORrlp
Category
Health
Be the first to comment